Report Overview
Mussel adhesive protein, also known as "soft gold of the ocean", was first discovered in the 1980s and belongs to the marine polyphenol protein family. The structural sequence of mussel adhesive protein is rich in lysine (Lys), arginine (Arg) and tyrosine (Tyr), which makes it have a strong positive charge at the physiological pH value of the human body. At the same time, it can form a large number of DOPA groups after being oxidized by tyrosinase. These physical and chemical properties give mussel adhesive protein a unique cell repair function. It can not only control the arrangement of cell repair in the wound area, thereby reducing scars, but also effectively adhere to the wound surface, play an isolating, moisturizing and anti-inflammatory effect, and promote the repair of skin damage caused by oxidation, ultraviolet radiation, allergies, etc.
The global Recombinant Mussel Mucin market size is projected to grow from US$ 47.2 million in 2024 to US$ 82.6 million in 2030; it is expected to grow at a CAGR of 9.8% from 2024 to 2030.
Analytic Insights Hub' newest research report, the “Recombinant Mussel Mucin Industry Forecast” looks at past sales and reviews total world Recombinant Mussel Mucin sales in 2023, providing a comprehensive analysis by region and market sector of projected Recombinant Mussel Mucin sales for 2024 through 2030. With Recombinant Mussel Mucin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Mussel Mucin industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Mussel Mucin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Mussel Mucin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Mussel Mucin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Mussel Mucin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Mussel Mucin.
United States market for Recombinant Mussel Mucin is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Recombinant Mussel Mucin is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Recombinant Mussel Mucin is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Recombinant Mussel Mucin players cover Kollodis BioSciences, JUYOU, PAML Biotechnology, Hangzhou Jiedi Biotechnology Co., Ltd., Jiangsu Jinpu Noan Biotechnology Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Mussel Mucin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Recombinant Mussel Mucin type I
Recombinant Mussel Mucin type II
Recombinant Mussel Mucin type III
Recombinant Mussel Mucin type V
Segmentation by Application:
Medical Bioadhesives
Wound Healing Materials
Medical and Beauty Field
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Kollodis BioSciences
JUYOU
PAML Biotechnology
Hangzhou Jiedi Biotechnology Co., Ltd.
Jiangsu Jinpu Noan Biotechnology Co., Ltd.
BD
Key Questions Addressed in this Report
What is the 10-year outlook for the global Recombinant Mussel Mucin market?
What factors are driving Recombinant Mussel Mucin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Mussel Mucin market opportunities vary by end market size?
How does Recombinant Mussel Mucin break out by Type, by Application?
Table Of Contents
Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2017-2029)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Recombinant Mussel Mucin Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Recombinant Mussel Mucin Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Recombinant Mussel Mucin Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by region)
5 Global Recombinant Mussel Mucin Market-Segmentation by Type
5.1 Type 1
5.2 Type 2
5.3 Type 3
6 Global Recombinant Mussel Mucin Market-Segmentation by Application
6.1 Application 1
6.2 Application 2
6.3 Application 3
7 Global Recombinant Mussel Mucin Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence A Company Profiles
8.1 Company 1
8.1.1 Company 1 Profile
8.1.2 Company 1 Sales, Growth Rate and Global Market Share from 2017-2023
8.1.3 Company 1 Product/Solution Launches and Enhancements Analysis
8.1.4 Company 1 Business Overview/Recent Development/Acquisitions
8.2 Company 2
8.2.1 Company 2 Profile
8.2.2 Company 2 Sales, Growth Rate and Global Market Share from 2017-2023
8.2.3 Company 2 Product/Solution Launches and Enhancements Analysis
8.2.4 Company 2 Business Overview/Recent Development/Acquisitions
8.3 Company 3
8.3.1 Company 3 Profile
8.3.2 Company 3 Sales, Growth Rate and Global Market Share from 2017-2023
8.3.3 Company 3 Product/Solution Launches and Enhancements Analysis
8.3.4 Company 3 Business Overview/Recent Development/Acquisitions
8.4 Company 4
8.4.1 Company 4 Profile
8.4.2 Company 4 Sales, Growth Rate and Global Market Share from 2017-2023
8.4.3 Company 4 Product/Solution Launches and Enhancements Analysis
8.4.4 Company 4 Business Overview/Recent Development/Acquisitions
8.5 Company 5
8.5.1 Company 5 Profile
8.5.2 Company 5 Sales, Growth Rate and Global Market Share from 2017-2023
8.5.3 Company 5 Product/Solution Launches and Enhancements Analysis
8.5.4 Company 5 Business Overview/Recent Development/Acquisitions
8.6 Company 6
8.6.1 Company 6 Profile
8.6.2 Company 6 Sales, Growth Rate and Global Market Share from 2017-2023
8.6.3 Company 6 Product/Solution Launches and Enhancements Analysis
8.6.4 Company 6 Business Overview/Recent Development/Acquisitions
8.7 Company 7
8.7.1 Company 7 Profile
8.7.2 Company 7 Sales, Growth Rate and Global Market Share from 2017-2023
8.7.3 Company 7 Product/Solution Launches and Enhancements Analysis
8.7.4 Company 7 Business Overview/Recent Development/Acquisitions
8.8 Company 8
8.8.1 Company 8 Profile
8.8.2 Company 8 Sales, Growth Rate and Global Market Share from 2017-2023
8.8.3 Company 8 Product/Solution Launches and Enhancements Analysis
8.8.4 Company 8 Business Overview/Recent Development/Acquisitions
8.9 Company 9
8.9.1 Company 9 Profile
8.9.2 Company 9 Sales, Growth Rate and Global Market Share from 2017-2023
8.9.3 Company 9 Product/Solution Launches and Enhancements Analysis
8.9.4 Company 9 Business Overview/Recent Development/Acquisitions
8.10 Company 10
8.10.1 Company 10 Profile
8.10.2 Company 10 Sales, Growth Rate and Global Market Share from 2017-2023
8.10.3 Company 10 Product/Solution Launches and Enhancements Analysis
8.10.4 Company 10 Business Overview/Recent Development/Acquisitions
8.11 Company 11
8.11.1 Company 11 Profile
8.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2017-2023
8.11.3 Company 11 Product/Solution Launches and Enhancements Analysis
8.11.4 Company 11 Business Overview/Recent Development/Acquisitions
8.12 Company 12
8.12.1 Company 12 Profile
8.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2017-2023
8.12.3 Company 12 Product/Solution Launches and Enhancements Analysis
8.12.4 Company 12 Business Overview/Recent Development/Acquisitions
8.13 Company 13
8.13.1 Company 13 Profile
8.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2017-2023
8.13.3 Company 13 Product/Solution Launches and Enhancements Analysis
8.13.4 Company 13 Business Overview/Recent Development/Acquisitions
8.14 Company 14
8.14.1 Company 14 Profile
8.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2017-2023
8.14.3 Company 14 Product/Solution Launches and Enhancements Analysis
8.14.4 Company 14 Business Overview/Recent Development/Acquisitions
8.15 Company 15
8.15.1 Company 15 Profile
8.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2017-2023
8.15.3 Company 15 Product/Solution Launches and Enhancements Analysis
8.15.4 Company 15 Business Overview/Recent Development/Acquisitions
9 Global Recombinant Mussel Mucin Market-Segmentation by Geography
10 North America
10.1 North America Recombinant Mussel Mucin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
10.2 North America Recombinant Mussel Mucin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
10.3 North America Recombinant Mussel Mucin Production Analysis from 2017-2023
10.4 North America Recombinant Mussel Mucin Consumption Analysis from 2017-2023
10.5 North America Recombinant Mussel Mucin Import and Export from 2017-2023
10.6 North America Recombinant Mussel Mucin Value, Production and Market Share by Type (2017-2023)
10.7 North America Recombinant Mussel Mucin Consumption, Value and Market Share by Application (2017-2023)
10.8 North America Recombinant Mussel Mucin by Country (United States, Canada)
10.8.1 North America Recombinant Mussel Mucin Sales by Country (2017-2023)
10.8.2 North America Recombinant Mussel Mucin Consumption Value by Country (2017-2023)
10.9 North America Recombinant Mussel Mucin Market PEST Analysis
11 Europe
11.1 Europe Recombinant Mussel Mucin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
11.2 Europe Recombinant Mussel Mucin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
11.3 Europe Recombinant Mussel Mucin Production Analysis from 2017-2023
11.4 Europe Recombinant Mussel Mucin Consumption Analysis from 2017-2023
11.5 Europe Recombinant Mussel Mucin Import and Export from 2017-2023
11.6 Europe Recombinant Mussel Mucin Value, Production and Market Share by Type (2017-2023)
11.7 Europe Recombinant Mussel Mucin Consumption, Value and Market Share by Application (2017-2023)
11.8 Europe Recombinant Mussel Mucin by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Recombinant Mussel Mucin Sales by Country (2017-2023)
11.8.2 Europe Recombinant Mussel Mucin Consumption Value by Country (2017-2023)
11.9 Europe Recombinant Mussel Mucin Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Recombinant Mussel Mucin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
12.2 Asia-Pacific Recombinant Mussel Mucin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
12.3 Asia-Pacific Recombinant Mussel Mucin Production Analysis from 2017-2023
12.4 Asia-Pacific Recombinant Mussel Mucin Consumption Analysis from 2017-2023
12.5 Asia-Pacific Recombinant Mussel Mucin Import and Export from 2017-2023
12.6 Asia-Pacific Recombinant Mussel Mucin Value, Production and Market Share by Type (2017-2023)
12.7 Asia-Pacific Recombinant Mussel Mucin Consumption, Value and Market Share by Application (2017-2023)
12.8 Asia-Pacific Recombinant Mussel Mucin by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Recombinant Mussel Mucin Sales by Country (2017-2023)
12.8.2 Asia-Pacific Recombinant Mussel Mucin Consumption Value by Country (2017-2023)
12.9 Asia-Pacific Recombinant Mussel Mucin Market PEST Analysis
13 Latin America
13.1 Latin America Recombinant Mussel Mucin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
13.2 Latin America Recombinant Mussel Mucin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
13.3 Latin America Recombinant Mussel Mucin Production Analysis from 2017-2023
13.4 Latin America Recombinant Mussel Mucin Consumption Analysis from 2017-2023
13.5 Latin America Recombinant Mussel Mucin Import and Export from 2017-2023
13.6 Latin America Recombinant Mussel Mucin Value, Production and Market Share by Type (2017-2023)
13.7 Latin America Recombinant Mussel Mucin Consumption, Value and Market Share by Application (2017-2023)
13.8 Latin America Recombinant Mussel Mucin by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Recombinant Mussel Mucin Sales by Country (2017-2023)
13.8.2 Latin America Recombinant Mussel Mucin Consumption Value by Country (2017-2023)
13.9 Latin America Recombinant Mussel Mucin Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Recombinant Mussel Mucin Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023
14.2 Middle East & Africa Recombinant Mussel Mucin Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023
14.3 Middle East & Africa Recombinant Mussel Mucin Production Analysis from 2017-2023
14.4 Middle East & Africa Recombinant Mussel Mucin Consumption Analysis from 2017-2023
14.5 Middle East & Africa Recombinant Mussel Mucin Import and Export from 2017-2023
14.6 Middle East & Africa Recombinant Mussel Mucin Value, Production and Market Share by Type (2017-2023)
14.7 Middle East & Africa Recombinant Mussel Mucin Consumption, Value and Market Share by Application (2017-2023)
14.8 Middle East & Africa Recombinant Mussel Mucin by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Recombinant Mussel Mucin Sales by Country (2017-2023)
14.8.2 Middle East & Africa Recombinant Mussel Mucin Consumption Value by Country (2017-2023)
14.9 Middle East & Africa Recombinant Mussel Mucin Market PEST Analysis
15 Future Forecast of the Global Recombinant Mussel Mucin Market from 2023-2029
15.1 Future Forecast of the Global Recombinant Mussel Mucin Market from 2023-2029 Segment by Region
15.2 Global Recombinant Mussel Mucin Production and Growth Rate Forecast by Type (2023-2029)
15.3 Global Recombinant Mussel Mucin Consumption and Growth Rate Forecast by Application (2023-2029)
16 Appendix
16.1 Methodology
16.2 Research Data Source